Small copper sulfide nanoparticles (s-Cu2-xS NPs, 0 < x < 1) with a core size of less than 5.5 nm have unique physicochemical characteristics and pharmacokinetic properties and have attracted substantial attention from researchers in the field of biomedicine in recent years. After exposure to near-infrared (NIR) light, s-Cu2-xS NPs can rapidly convert light energy into heat for photoacoustic imaging (PAI) and photothermal therapy (PTT). In addition, the potential for magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging, along with the low toxicity and low cost, makes s-Cu2-xS NPs a promising multifunctional diagnostic reagent. This Review outlines recent advances in s-Cu2-xS NPs for molecular imaging and tumor therapy and discusses the challenges associated with successful clinical translation.
Keyphrases
- oxide nanoparticles
- pet imaging
- positron emission tomography
- computed tomography
- magnetic resonance imaging
- low cost
- metal organic framework
- aqueous solution
- photodynamic therapy
- contrast enhanced
- fluorescence imaging
- drug delivery
- working memory
- high resolution
- pet ct
- stem cells
- oxidative stress
- cancer therapy
- climate change
- drug release
- heat stress
- mass spectrometry